BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31469058)

  • 1. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancer.
    Gockel I; Jansen-Winkeln B; Haase L; Niebisch S; Moulla Y; Lyros O; Lordick F; Schierle K; Wittekind C; Thieme R
    Tumori; 2020 Feb; 106(1):70-78. PubMed ID: 31469058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Cancer Patients with Peritoneal Metastasis (PM): Results of a Single-Center Experience and Register Study.
    Gockel I; Jansen-Winkeln B; Haase L; Rhode P; Mehdorn M; Niebisch S; Moulla Y; Lyros O; Lordick F; Schierle K; Wittekind C; Thieme R
    J Gastric Cancer; 2018 Dec; 18(4):379-391. PubMed ID: 30607301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Alyami M; Mercier F; Siebert M; Bonnot PE; Laplace N; Villeneuve L; Passot G; Glehen O; Bakrin N; Kepenekian V
    Eur J Surg Oncol; 2021 Jan; 47(1):128-133. PubMed ID: 31253545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review.
    Ploug M; Graversen M; Pfeiffer P; Mortensen MB
    BMC Cancer; 2020 Feb; 20(1):105. PubMed ID: 32041558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer.
    Alyami M; Bonnot PE; Mercier F; Laplace N; Villeneuve L; Passot G; Bakrin N; Kepenekian V; Glehen O
    Eur J Surg Oncol; 2021 Jan; 47(1):123-127. PubMed ID: 32561204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study.
    Jansen-Winkeln B; Eberth J; Moulla Y; Mehdorn M; Niebisch S; Schierle K; Bläker H; Lordick F; Gockel I; Thieme R
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1331-1341. PubMed ID: 36513815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
    Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis.
    Larbre V; Alyami M; Mercier F; Vantard N; Bonnefoy I; Opsomer MA; Villeneuve L; Bakrin N; Rioufol C; Glehen O; Kepenekian V
    Anticancer Res; 2018 Dec; 38(12):6869-6875. PubMed ID: 30504403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
    Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
    Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Graversen M; Detlefsen S; Bjerregaard JK; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2017 Jun; 34(5):309-314. PubMed ID: 28516306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis.
    Tidadini F; Abba J; Quesada JL; Trilling B; Bonne A; Foote A; Faucheron JL; Arvieux C
    J Gastrointest Cancer; 2023 Jun; 54(2):632-641. PubMed ID: 35778645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer - study protocol for a randomized control trial.
    Somashekhar SP; Ashwin KR; Rauthan A; Rohit KC
    Pleura Peritoneum; 2019 Mar; 4(1):20180111. PubMed ID: 31198851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Clinical Data of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) as Salvage Therapy for Peritoneal Metastatic Biliary Tract Cancer.
    Falkenstein TA; Götze TO; Ouaissi M; Tempfer CB; Giger-Pabst U; Demtröder C
    Anticancer Res; 2018 Jan; 38(1):373-378. PubMed ID: 29277797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis.
    Nadiradze G; Giger-Pabst U; Zieren J; Strumberg D; Solass W; Reymond MA
    J Gastrointest Surg; 2016 Feb; 20(2):367-73. PubMed ID: 26511950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.
    Luksta M; Bausys A; Bickaite K; Rackauskas R; Paskonis M; Luksaite-Lukste R; Ranceva A; Stulpinas R; Brasiuniene B; Baltruskeviciene E; Lachej N; Sabaliauskaite R; Bausys R; Tulyte S; Strupas K
    BMC Cancer; 2023 Oct; 23(1):1032. PubMed ID: 37875869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
    Dumont F; Senellart H; Pein F; Campion L; Glehen O; Goere D; Pocard M; Thibaudeau E
    Pleura Peritoneum; 2018 Sep; 3(3):20180120. PubMed ID: 30911664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.